Change in use of gadolinium-enhanced magnetic resonance studies in kidney disease patients after US Food and Drug Administration warnings: A cross-sectional study of veterans affairs health care system data from 2005-2008

American Journal of Kidney Diseases

Volumn 56, Issue 3, 2010, Pages 458-467

  Kim, Kyung Ho ^a   Fonda, Jennifer R ^b   Lawler, Elizabeth V ^b,c   Gagnon, David ^b,d   Kaufman, James S ^e  

^a STONY BROOK UNIVERSITY   (United States)

^b VA BOSTON HEALTHCARE SYSTEM   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

chronic kidney disease; Gadolinium; glomerular filtration rate; magnetic resonance; nephrogenic systemic fibrosis; US Food and Drug Administration

Indexed keywords

CREATININE; GADOLINIUM CHELATE; CONTRAST MEDIUM; GADOLINIUM;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIALYSIS; FEMALE; FOOD AND DRUG ADMINISTRATION; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; SIDE EFFECT; UNITED STATES; ADOLESCENT; BLOOD; DRUG SURVEILLANCE PROGRAM; DRUG UTILIZATION; FACTUAL DATABASE; GOVERNMENT; KIDNEY DISEASE; MIDDLE AGED; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; CREATININE; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; DRUG UTILIZATION; FEMALE; GADOLINIUM; GLOMERULAR FILTRATION RATE; GUIDELINE ADHERENCE; HUMANS; KIDNEY DISEASES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; UNITED STATES FOOD AND DRUG ADMINISTRATION; YOUNG ADULT;

EID: 77956212512     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2010.03.027     Document Type: Article

References (24)

1. S. Cowper, H. Robin, S. Steinberg, L. Su, S. Gupta, and P. Leboit Scleromyxoedema-like cutaneous diseases in renal-dialysis patients Lancet 356 9234 2000 1000 1001
2. S. Cowper, L. Su, J. Bhawan, H. Robin, and P. Leboit Nephrogenic fibrosing dermopathy Am J Dermatopathol 23 5 2001 383 393
3. R. Swartz, L. Crofford, S. Phan, R. Ike, and L. Su Nephrogenic fibrosing dermopathy: a novel cutaneous fibrosis disorder in patients with renal failure Am J Med 114 7 2003 563 572
4. T. Grobner Gadoliniuma specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21 4 2006 1104 1108
5. P. Marckmann, L. Skov, and K. Rossen Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging J Am Soc Nephrol 17 9 2006 2359 2362
6. US Food and Drug Administration Public health advisory: gadolinium-containing contrast agents for magnetic resonance imaging (MRI): Omniscan, OptiMARK, Magnevist, ProHance, and MultiHance http://www.fda.gov/ Drugs/DrugSafety/PublicHealthAdvisories/ucm053112.htm Accessed June 22, 2009
7. US Food and Drug Administration Public health advisory: update on magnetic resonance imaging (MRI) containing gadolinium and nephrogenic fibrosing dermapathy http://www.fda.gov/Drugs/DrugSafety/PublicHealthAdvisories/ ucm124344.htm Accessed June 22, 2009
8. US Food and Drug Administration Information for healthcare professionals: gadolinium based-contrast agents for magnetic resonance imaging (marketed as Magnevist, MultiHance, Omniscan, OptiMARK and ProHance) http://www.fda.gov/ Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ ucm142884.htm Accessed June 22, 2009
9. H.S. Thomsen, T. Almen, S.K. Morcos Members of Contrast Media Safety Committee of European Society of Urogenital Radiology Gadolinium-containing contrast media for radiographic examinations: a position paper Eur Radiol 12 10 2002 2600 2605
10. J. Coresh, D. Byrd-Holt, and B. Astor Chronic kidney disease awareness, prevalence, and trends among US adults, 1999-2000 J Am Soc Nephrol 16 1 2005 180 188
11. A.S. Levey, T. Green, J.W. Kusek, G.L. Beck MDRD Study Group A simplified equation to predict glomerular filtration rate from serum creatinine [abstract A0848] J Am Soc Nephrol 11 2000 155A
12. P. Marckmann Nephrogenic systemic fibrosis: epidemiology update Curr Opin Nephrol Hypertens 17 3 2008 315 319
13. T.A. Collidge, P.C. Thompson, and P.B. Mark Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort Radiology 245 1 2007 168 175
14. A. Deo, M. Fogel, and S.E. Cowper Nephrogenic systemic fibrosis: a population study examining the relationship of disease development to gadolinium exposure Clin J Am Soc Nephrol 2 2 2007 264 267
15. D.R. Broome, M.S. Girguis, and P.W. Baron Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned AJR Am J Roentgenol 188 2 2007 586 592
16. The Danish Medicines Agency Investigation of the safety of MRI contrast medium Omniscan http://www.dkma.dk/1024/visUKLSArtikel.asp?artikelID=8931 Accessed June 22, 2009
17. C. Ryadahl, H.S. Thomsen, and P. Marckmann High prevalence of nephrogenic systemic fibrosis in chronic renal failure patients exposed to gadodiamide, a gadolinium-containing magnetic resonance contrast agent Invest Radiol 43 2 2008 141 144
18. T. Lineberry, M. Bostwick, T. Beebe, and P. Decker Impact of the FDA black box warning on physician antidepressant prescribing and practice patterns: opening the Pandora's suicide box [letter] Mayo Clin Proc 82 4 2007 516 522
19. US Food and Drug Administration FDA public health advisory: suicidality in children and adolescents being treated with antidepressant medications http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm096273.htm Accessed June 22, 2009
20. J. Rosack New data show declines in antidepressant prescribing Psychiatric News 40 2005 1 7 [serial online] http://pn.psychiatryonline.org/cgi/ content/full/40/17/1-a Accessed June 22, 2009
21. H.S. Thomsen European Society of Urogenital Radiology (ESUR) ESUR guideline: gadolinium-based contrast media and nephrogenic systemic fibrosis Eur Radiol 17 10 2007 2692 2696
22. R. Tippins, W. Torres, B. Baumgartner, and D. Baumgarten Are screening serum creatinine levels necessary prior to outpatient CT examinations? Radiology 216 2 2000 481 484
23. R. Duszak, W. Blackham, G. Kusiak, and J. Majchrzak CPT coding by interventional radiologists: a multi-institutional evaluation of accuracy and its economic implications J Am Coll Radiol 1 10 2004 734 740
24. E. Kanal, J. Barkovitch, and C. Bell ACR guidance document for safe MR practices: 2007 AJR Am J Roentgenol 188 6 2007 1447 1474